{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:52:04Z","timestamp":1764510724570,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jiac.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T11:09:13Z","timestamp":1613387353000},"page":"1230-1233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report"],"prefix":"10.1016","volume":"27","author":[{"given":"Koichi","family":"Onodera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-7835","authenticated-orcid":false,"given":"Jun","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Yonha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-0687","authenticated-orcid":false,"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jiac.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.bbmt.2015.07.033","article-title":"Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American society for blood and marrow transplantation task force recommendations","volume":"21","author":"Torres","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jiac.2021.02.002_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bmt.2015.205","article-title":"Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation","volume":"51","author":"Arai","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jiac.2021.02.002_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbmt.2015.12.010","article-title":"Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jiac.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705120","article-title":"Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients","volume":"36","author":"Peffault de Latour","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jiac.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.6004\/jnccn.2015.0007","article-title":"Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population","volume":"13","author":"Torres","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.jiac.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2010-07-295279","article-title":"A\u00a0randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study","volume":"117","author":"Miyawaki","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jiac.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/tid.12474","article-title":"Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant","volume":"18","author":"Pinana","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jvh.13046","article-title":"Durable control of hepatitis C through interferon-free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantation","volume":"26","author":"Rauwolf","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.jiac.2021.02.002_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13091","article-title":"Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplant","volume":"21","author":"Cunningham","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2021.02.002_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13520","article-title":"Safety of allogeneic hematopoietic stem cell transplantation in beta-thalassemia patients with chronic hepatitis C infections treated at a pediatric center","volume":"23","author":"Ramgopal","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.jiac.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","article-title":"Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients","volume":"57","author":"Mahale","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jiac.2021.02.002_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/hep.29344","article-title":"Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study","volume":"67","author":"Torres","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jiac.2021.02.002_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14653240701231014","article-title":"Immune reconstitution after unrelated cord blood transplantation","volume":"9","author":"Szabolcs","year":"2007","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jiac.2021.02.002_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.cgh.2013.10.034","article-title":"Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals?","volume":"12","author":"Mahale","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.jiac.2021.02.002_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s40265-016-0648-2","article-title":"Sofosbuvir\/velpatasvir: a review in chronic hepatitis C","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2021.02.002_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12072-018-9878-6","article-title":"Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis c who failed direct-acting antivirals","volume":"12","author":"Izumi","year":"2018","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jiac.2021.02.002_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:54Z","timestamp":1761159714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1341321X21000337"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.02.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}